Patent · US Active

Intravenous infusion dosage form

US10869867B2 · kind B2 · utility

1Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2016
Grant dateDec 22, 2020
Priority date
Expiry dateApr 7, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M5/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.